Literature DB >> 1375178

Increased levels of substance P in the myenteric plexus of Trichinella-infected rats.

M G Swain1, A Agro, P Blennerhassett, A Stanisz, S M Collins.   

Abstract

Changes in immunoreactive substance P concentrations were investigated in longitudinal muscle-myenteric plexus preparations from the inflamed jejunum of Trichinella spiralis-infected rats. The substance P concentration increased within 2 days of infection and increased fivefold by day 6; in contrast, there was no significant increase in substance P in the noninflamed ileum. In vitro exposure of preparations from infected rats to scorpion venom reduced substance P levels by 88%. In addition, no increase in substance P was observed in rats that had been treated with capsaicin as neonates or as adults before infection. Treatment of infected rats with betamethasone attenuated the inflammatory response to the infection and prevented the increase in substance P. Furthermore, no significant increase in substance P concentration was seen in congenitally athymic rats infected with T. spiralis. This study is consistent with the hypothesis that inflammation increases substance P in myenteric nerves by a process that involves T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375178     DOI: 10.1016/0016-5085(92)90313-n

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Role of nerves in enteric infection.

Authors:  R C Spiller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Alterations in intestinal contractility during inflammation are caused by both smooth muscle damage and specific receptor-mediated mechanisms.

Authors:  Adnan Tanović; Ester Fernández; Marcel Jiménez
Journal:  Croat Med J       Date:  2006-04       Impact factor: 1.351

3.  Modulation of gut substance P after whole-body irradiation. A new pathological feature.

Authors:  V Esposito; C Linard; C Maubert; J Aigueperse; P Gourmelon
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

Review 4.  Diverticulosis today: unfashionable and still under-researched.

Authors:  Antonio Tursi
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

5.  Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P.

Authors:  S Sturiale; G Barbara; B Qiu; M Figini; P Geppetti; N Gerard; C Gerard; E F Grady; N W Bunnett; S M Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse.

Authors:  G Barbara; R De Giorgio; V Stanghellini; R Corinaldesi; C Cremon; N Gerard; C Gerard; E F Grady; N W Bunnett; P A Blennerhassett; S M Collins
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Colitis affects the smooth muscle and neural response to motilin in the rabbit antrum.

Authors:  Inge Depoortere; Theo Thijs; Sara Janssen; Betty De Smet; Jan Tack
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

8.  Synaptic plasticity: the new explanation of visceral hypersensitivity in rats with Trichinella spiralis infection?

Authors:  Xiaojun Yang; Lei Sheng; Yang Guan; Wei Qian; Xiaohua Hou
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

9.  CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

Authors:  C Pothoulakis; I Castagliuolo; J T LaMont; A Jaffer; J C O'Keane; R M Snider; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Involvement of primary afferent nerves after abdominal irradiation: consequences on ileal contractile activity and inflammatory mediator release in the rat.

Authors:  Christine Linard; Christel Marquette; Carine Strup; Jocelyne Aigueperse; Denis Mathe
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.